Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

NCT01477632 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause
Healthy

Interventions

DRUG: 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)
DRUG: 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA)
DRUG: 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)

Sponsor

Novo Nordisk A/S